-
Peginesatide (INN/USAN,
trade name Omontys,
formerly Hematide),
developed by
Affymax and Takeda, is an
erythropoietic agent, a
functional analog of erythropoietin...
- Hertfordshire. Also that year,
Glaxo Wellcome acquired the California-based
Affymax, a
leader in the
field of
combinatorial chemistry. By 1999,
Glaxo Wellcome...
- billion,
which closed on
March 31, 2016. Affymetrix, Inc. was spun-off from
Affymax Research Institute by Alex
Zaffaroni in 1993, and was
eventually based...
- work
continued at
Affymax with
support from
USAID and
Affymax,
leading to
cloning of the PfEMP1 gene
while at
Affymax.
After Affymax was
purchased by GlaxoWellcome...
-
technology supplier to a
number of
pharmaceutical companies including Affymax, Amgen, Merck,
Pfizer and UCB Pharma, etc. The
company developed the world's...
-
Zaffaroni and Dr.
Peter G. Schultz, Symyx'
conceptual basis drew from
Affymax, Inc. and Affymetrix, Inc.,
which commercialized the use of high-speed...
- ****ociated with
chronic kidney disease in
adult patients on
dialysis (
Affymax/Takeda Pharmaceuticals, 2012)
Pegloticase (Krystexxa) –
PEGylated uricase...
- candidates.
Schultz is a
founder of
several biotechnology startups,
including Affymax Research Institute,
Symyx Technologies, Syrrx, Kalypsys, Phenomix, Ilypsa...
- "Stephen P.A. Fodor,
Michael C. Pirrung, J.
Leighton Read and
Lubert Stryer (
Affymax Research Institute, Palo Alto, USA)". epo.org.
Retrieved 2022-03-22. "Dr...
-
Stephen P.A. Fodor,
Michael C. Pirrung, J.
Leighton Read and
Lubert Stryer (
Affymax Research Institute, Palo Alto, USA)". "Faculty & Research". "Meyer Lab"...
